The 2007 AAPS (American Association of Pharmaceutical Scientists) National Biotechnology Conference (NBC) was hosted in sunny San Diego, California, from June 24–27. With a mild breeze, the temperature ranged between 70° and 75° F, one could only hope that the meeting would have taken place on the beautiful sandy beaches, instead of in a stuffy […]
Gamma Medica-Ideas, a provider of preclinical imaging instruments for in vivo small-animal imaging, was founded as Gamma Medica in 2000. In June 2005, Gamma Medica merged with the Norwegian company Ideas ASA, a manufacturer of solid-state digital detector electronics and imaging detector subsystems, to form Gamma Medica-Ideas (see IBO 10/15/05). Gamma Medica-Ideas has 85 employees. […]
In the June 30 issue, IBO examined the acquisition of molecular diagnostic providers by companies traditionally associated with research instrumentation and products. QIAGEN NV is one such company. QIAGEN currently offers 34 CE-marked IVD assays, six CE-marked IVD sample preparation products, nine China State Food and Drug Administration– approved IVD assays and one FDA 510K-approved […]
St. Louis, MS and Richmond, CA 7/10/07—Sigma-Aldrich has licensed Sangamo BioSciences’ zinc finder DNA-binding proteins (ZFPs) for development of research reagents for the regulation of gene expression in living cells. Sigma-Aldrich also acquired rights to sublicense the technology for research applications. Sigma-Aldrich will initially pay Sangamo $13.75 million in the form of an upfront licensing […]
In 2006, the German Research Foundation (DFG) had €1.41 billion ($1.76 billion) in income, according to the foundation’s annual report. Of this income, 58.2% came from the national government, 41.0% from local government and 0.4% from foundations and private companies. In the first round of the Excellence Initiative, 18 graduate schools, 17 clusters of excellence […]
Numerous countries are funding national nanotechnology efforts in order to develop the R&D and infrastructure capabilities to support private and public opportunities in nanotech technologies and products in fields ranging from medicine, to semiconductors, to chemicals. At stake is industrial and scientific leadership in a new field whose potential impact has been compared to biotechnology […]
SGE Analytical Services signed a joint R&D agreement with the Australian Proteome Facility for applications of its ProteCol LC platform and microfabrication technologies for protein biomarker discovery. Waters entered into a Cooperative Research and Development Agreement with the EPA’s National Exposure Research Laboratory to develop trace level analytical methods for detecting perfluorinated compounds in soil […]
A report by the Department for Innovation, Universities and Skills has found that UK researchers are collaborating with their international colleagues roughly 50% more than they did a decade ago. The UK trails Germany in terms of research links to the US, the global leader in research; however, the UK is the US’ top partner […]
According to the Chinese state press, Premier Wen Jiabao announced that a clean water supply has become a national priority. This statement comes after outbreaks of blue-green algae in Taihu, Chaohu and Dianchi, three of China’s largest lakes. In June, China adopted a new standard for tap water quality, replacing a standard issued in 1985 […]
A number of biotechnology companies are moving into the market for combination drugs, which are mixtures of two already-approved drugs. Most companies are drawn to the cost-saving opportunities that lie in combining two drugs that have already been approved. Prominent firms in the combination drugs business include CombinatoRx, Pozen and Orexigen. The increasing number of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
